GlaxoSmithKline (GSK) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 01/29/22
Should GlaxoSmithKline Have Accepted Unilever's $68 Billion Consumer Health Offer?The Motley Fool • 01/28/22
GlaxoSmithKline names Tony Wood chief scientific officer to succeed Hal BarronProactive Investors • 01/19/22
Unilever yet to demonstrate it would be the right owner of GSK's Consumer Healthcare divisionProactive Investors • 01/17/22